|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.990 USD | -5.85% |
|
-6.85% | -12.82% |
Company Valuation: Unicycive Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 145.2 | - | - |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 17.08% | - | - |
| Enterprise Value (EV) | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 145.2 | 145.2 | 145.2 |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 17.08% | 0% | 0% |
| P/E | -2.4x | -0.45x | -0.68x | -1.42x | -3.46x | -3.75x | 1.03x | 0.55x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | -0.1x | 0x | 0x | 0.2x | -0x | 0x |
| Capitalization / Revenue | - | 8.57x | 44.7x | - | - | 38.2x | 0.5x | 0.26x |
| EV / Revenue | - | 0x | 0x | - | - | 38.2x | 0.5x | 0.26x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.65x | 0.7x | 0.38x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -5.38x | -3.99x | 0.87x |
| FCF Yield | -18.8% | - | -60.7% | -34.8% | -25.3% | -18.6% | -25% | 115% |
| Dividend per Share 2 | - | - | - | - | - | - | 2.3 | 5.8 |
| Rate of return | - | - | - | - | - | - | 43.4% | 109% |
| EPS 2 | -8.6 | -12 | -12.8 | -5.6 | -1.67 | -1.415 | 5.146 | 9.648 |
| Distribution rate | - | - | - | - | - | - | 44.7% | 60.1% |
| Net sales 1 | - | 0.951 | 0.675 | - | - | 3.804 | 288.4 | 566.6 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.977 | -18.05 | -20.77 | -32.12 | -29.52 | -39.78 | 208.2 | 386.1 |
| Net income 1 | -10.02 | -18.06 | -31.41 | -37.82 | -26.56 | -40.34 | 186.2 | 366.7 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.600 | 5.400 | 8.677 | 7.942 | 5.770 | 5.300 | 5.300 | 5.300 |
| Nbr of stocks (in thousands) | 1,497 | 1,509 | 3,475 | 10,380 | 21,491 | 27,393 | - | - |
| Announcement Date | 3/31/22 A | 3/31/23 A | 3/28/24 A | 3/31/25 A | 3/30/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.75x | - | - | - | 145M | |
| 20.76x | 6.35x | 13.89x | 1.53% | 55.23B | |
| 31.7x | 7.83x | 24.1x | 0.05% | 53.75B | |
| -18.35x | 4.4x | -7.71x | -.--% | 23.48B | |
| -39.73x | 12.6x | -37.13x | -.--% | 22B | |
| 24.86x | 4.85x | 12.85x | -.--% | 19.78B | |
| 24.09x | 4.69x | 15.26x | -.--% | 17.44B | |
| -736.67x | 34.86x | -3924.15x | -.--% | 14.66B | |
| 17.61x | 5.1x | 11.9x | -.--% | 14.07B | |
| 39.36x | 15.8x | 40.68x | 0.09% | 13.02B | |
| Average | -64.01x | 10.72x | -427.81x | 0.19% | 23.36B | |
| Weighted average by Cap. | -32.46x | 9.08x | -236.65x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNCY Stock
- Valuation Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
